期刊文献+

以2015版Beers标准评价老年住院患者潜在不适当用药

Evaluation of potentially inappropriate medication among elderly inpatients by 2015 edition of beers criteria
下载PDF
导出
摘要 目的:为提高临床合理用药水平,减少潜在不适当用药。方法:以Beers标准(2015版)为依据,对本院内科800例住院老年患者用药潜在风险进行评价。结果:800例患者中,平均年龄(76. 31±6. 25)岁,平均用药品种为(15. 31±5. 73)种。按照Beers标准,307例存在PIM 473项,使用频度最高的为质子泵抑制剂(19. 66%),其次为苯二氮艹卓类药物(16. 07%)和胰岛素(10. 78%)。结论:本院老年住院患者潜在不适当用药情况较严重,应采取多种措施预防其不合理用药。 Objective: To improve clinical rational drug use and reduce potentially inappropriate medication (PIM). Methods: Based on Beers criteria (2015 edition),PIM of 800 elderly inpatients in internal medicine department of our hospital were evaluated. Results: Among the 800 patients, the average age was 76.31±6.25 years,and the average medication varieties were 15.31±5.73. According to Beers criteria, 473 PIM items were found in 307 cases, and the top three frequently PIM drug categories in our hospital were proton pump inhibitors (19.66%), benzodiazepines (16.07%) and insulin (10.78%). Conclusions: A high prevalence of PIM among elderly inpatients in our hospital requires various measures to prevent its occurrence.
作者 薛建爱 Xue Jianai(Tianjin Fourth Central Hospital, Tianjin 300140)
出处 《天津药学》 2019年第2期34-36,共3页 Tianjin Pharmacy
关键词 Beer标准 老年患者 潜在不适当用药 Beers criteria Elderly patients Potentially inappropriate medication
  • 相关文献

参考文献7

二级参考文献133

  • 1Ji Won Kim,Kook Lae Lee,Ji Bong Jeong,Byeong Gwan Kim,Sue Shin,Joo Sung Kim,Hyun Chae Jung,In Sung Song.Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea[J].World Journal of Gastroenterology,2010,16(28):3573-3577. 被引量:10
  • 2Junichi Iwamoto,Yoshifumi Saito,Akira Honda,Yasushi Matsuzaki.Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy[J].World Journal of Gastroenterology,2013,19(11):1673-1682. 被引量:33
  • 3全国老龄工作委员会办公室.中国人口老龄化发展趋势预测研究报告[EB/OL].[2006-02-24].http://www.xinhuanet.com/newscenter/. 被引量:54
  • 42010年第六次全国人口普查主要数据公报.http://www.stats.gov.cn/tjgb/rkpcgb/qgrkpcgb/t20110429_402722510.htm,2011-3-26. 被引量:13
  • 5Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient [ J 1. Nat Rev Gastroenterol Hepatol, 2015, 12(2) :9$-107. 被引量:1
  • 6Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? [J]. Curr Opin Crit Care, 2009, 15(2) :139-143. 被引量:1
  • 7Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group[J~. N Engl J Med, 1994, 330(6) :377-381. 被引量:1
  • 8Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients [ J ]. J Crit Care, 2005, 20 (1) :35-45. 被引量:1
  • 9ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998 [ J]. Am J Health Syst Pharm, 1999, 56(4) :347-379. 被引量:1
  • 10Spirt M J, Stanley S. Update on stress ulcer prophylaxis in critically ill patients [ J ]. Crit Care Nurse, 2006, 26 ( 1 ) : 18-20, 22 -25. 被引量:1

共引文献463

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部